Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

Author： Gattaz Wagner F.   Campos João Alberto de Oliveira   Lacerda Acioly L.T.   Henna Elaine   Ruschel Sandra Inês   Bressan Rodrigo A.   de Oliveira Irismar Reis   Rocha Fábio Lopes   Grabowski Hamilton M.   Sacomani Ernindo   Louzã Mario R.   Quevedo João   Elkis Hélio   Filho Dirceu Zorzetto   Périco Cintia de Azevedo-Marques   Lawson Fábio Lorea   Appolinário José Carlos  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.30, Iss.4, 2014-04, pp. : 695-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

By Kim Eun Young   Chang Sung Man   Shim Joo Cheol   Joo Eun Jeong   Kim Jae Jin   Kim Yong Sik   Ahn Yong Min  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Järbrink Krister   Kreif Noemi   Benedict Agnes   Locklear Julie  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 709-716

Informa Healthcare

Access to resources Recommend Favorite

Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion

By Arnold L.E.   Bozzolo D.R.   Hodgkins P.   McKay M.   Beckett-Thurman L.   Greenbaum M.   Bukstein O.   Patel A.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 129-137

Informa Healthcare

Access to resources Recommend Favorite

Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Ganesan S.   Agambaram V.   Randeree F.   Eggens I.   Huizar K.   Meulien D.    

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 21-32

Informa Healthcare

Access to resources Recommend Favorite

Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study

By Gajria Kavita  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite